Trials / Unknown
UnknownNCT06208436
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer
The Survival Outcome of Adjuvant Chemotherapy for Stage I Pancreatic Cancer Stratified by Pathologic Risk Factors
- Status
- Unknown
- Phase
- —
- Study type
- Observational
- Enrollment
- 250 (estimated)
- Sponsor
- Tianjin Medical University Cancer Institute and Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years
- Healthy volunteers
- Not accepted
Summary
This study aimed to evaluate the impact of adjuvant chemotherapy on survival in patients with Stage I pancreatic cancer stratified by pathologic risk factors.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| OTHER | Adjuvant chemotherapy | Patients received adjuvant chemotherapy (5-FU-based or gemcitabine-based regimens) or underwent surgery alone |
Timeline
- Start date
- 2023-10-07
- Primary completion
- 2024-02-15
- Completion
- 2024-02-28
- First posted
- 2024-01-17
- Last updated
- 2024-01-17
Locations
1 site across 1 country: China
Source: ClinicalTrials.gov record NCT06208436. Inclusion in this directory is not an endorsement.